Treatment of patients with chronic malignant pain with intrathecal morphine
Ugeskrift for Læger · 2024
DOI: 10.61409/v08230541 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ugeskrift for Læger, 2024. Verfasst von Rares Miscov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neurokirurgisk Afdeling, Aalborg Universitetshospital. Hauptthemen laut MEDLINE: Morphine, Chronic Pain.
Abstract (Originalsprache)
Chronic malignant pain is a common and feared condition. Especially, since many patients do not achieve proper pain relief from conventional peroral medication regimes and possible unacceptable side effects of high dosing. As argued in this review, in these patients, continuous intrathecal infusion of pain medicine by a programmable subcutaneously placed pump enables good pain relief, less systemic side effects, and better life quality. Intrathecal pain treatment should therefore be considered in patients with a proper performance score and suitable estimated life expectancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neurokirurgisk Afdeling, Aalborg Universitetshospital.
Zitieren
APA
Miscov, R., Gulisano, H. A., & Bjarkam, C. R. (2024). Treatment of patients with chronic malignant pain with intrathecal morphine. Ugeskrift for Læger. https://doi.org/10.61409/v08230541
Vancouver
Miscov R, Gulisano HA, Bjarkam CR. Treatment of patients with chronic malignant pain with intrathecal morphine. Ugeskrift for Læger. 2024. doi:10.61409/v08230541
BibTeX
@article{Miscov2024,
author = {Miscov, Rares and Gulisano, Helga Angela and Bjarkam, Carsten Reidies},
title = {Treatment of patients with chronic malignant pain with intrathecal morphine},
journal = {Ugeskrift for Læger},
year = {2024},
doi = {10.61409/v08230541}
}
EUVIMED